Page last updated: 2024-08-22

cadmium and Familial Nonmedullary Thyroid Cancer

cadmium has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borković-Mitić, S; Gavrović-Jankulović, M; Jagodić, J; Krstić, Đ; Manojlović, D; Mitić, B; Paunović, I; Rovčanin, B; Stojsavljević, A; Živaljević, V1

Other Studies

1 other study(ies) available for cadmium and Familial Nonmedullary Thyroid Cancer

ArticleYear
Cadmium as main endocrine disruptor in papillary thyroid carcinoma and the significance of Cd/Se ratio for thyroid tissue pathophysiology.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2019, Volume: 55

    Topics: Cadmium; Endocrine Disruptors; Female; Humans; Male; Mass Spectrometry; Middle Aged; Selenium; Thyroid Cancer, Papillary

2019
chemdatabank.com